<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2015 (12) TMI 95 - ITAT HYDERABAD</title>
    <link>https://www.taxtmi.com/caselaws?id=268791</link>
    <description>The ITAT partly allowed the appeal, directing the AO to re-examine various adjustments and deductions. Specific directions were given on interest adjustments for short-term facilities and share application money, corporate guarantees, exclusion of specific incomes from operating profits, determination of Arm&#039;s Length Price, deduction of income corresponding to TP adjustments, disallowance under Section 10B, superannuation and gratuity contributions, ESOP expenses, apportionment of corporate overhead expenses, weighted deduction for clinical drug trials, disallowance under Section 14A, depreciation on non-compete fees, taxation of capital gains, and computation of book profits under Section 115JB.</description>
    <language>en-us</language>
    <pubDate>Wed, 26 Aug 2015 00:00:00 +0530</pubDate>
    <lastBuildDate>Mon, 08 Aug 2022 10:47:00 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=407252" rel="self" type="application/rss+xml"/>
    <item>
      <title>2015 (12) TMI 95 - ITAT HYDERABAD</title>
      <link>https://www.taxtmi.com/caselaws?id=268791</link>
      <description>The ITAT partly allowed the appeal, directing the AO to re-examine various adjustments and deductions. Specific directions were given on interest adjustments for short-term facilities and share application money, corporate guarantees, exclusion of specific incomes from operating profits, determination of Arm&#039;s Length Price, deduction of income corresponding to TP adjustments, disallowance under Section 10B, superannuation and gratuity contributions, ESOP expenses, apportionment of corporate overhead expenses, weighted deduction for clinical drug trials, disallowance under Section 14A, depreciation on non-compete fees, taxation of capital gains, and computation of book profits under Section 115JB.</description>
      <category>Case-Laws</category>
      <law>Income Tax</law>
      <pubDate>Wed, 26 Aug 2015 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=268791</guid>
    </item>
  </channel>
</rss>